Moody's: Biostime's ratings unaffected by disclosure of PGT option in collaboration agreement with Swisse
Announcement: Moody's: Biostime's ratings unaffected by disclosure of PGT option in collaboration agreement with Swisse. Global Credit Research- 15 May 2017. Hong Kong, May 15, 2017-- Moody's Investors Service says that Biostime International Holdings Limited's disclosure of PGT Healthcare LLP's option in the collaboration agreement between PGT and Swisse Wellness Group Pty Ltd, an Australian vitamin, herbal and mineral supplements provider that Biostime owns 100%, will...
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.